United States Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Applied Regulatory Science, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002, United States of America.
United States Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Division of Applied Regulatory Science, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002, United States of America.
J Pharmacol Toxicol Methods. 2021 Jul-Aug;110:107083. doi: 10.1016/j.vascn.2021.107083. Epub 2021 Jun 5.
It has recently become possible to produce hepatocytes from human induced pluripotent stem cells (iPSC-heps), which may offer some advantages over primary human hepatocytes (Prim-heps) in the regulatory environment. The aim of this research was to assess similarities and differences between commercially available iPSC-heps and Prim-heps in preliminary assays of drug metabolism, hepatotoxicity, and drug transport. Hepatocytes were either cultured in collagen-coated 96-well plates (Prim-heps and 2d-iPSC-heps) or in ultra-low adhesion plates as spheroids (3d-iPSC-heps). 3d-iPSC-heps were used to enhance physiological cell-cell contacts, which is essential to maintain the phenotype of mature hepatocytes. Cytochrome P450 (CYP) 3A4, CYP1A2, and CYP2B6 activity levels were evaluated using fluorescent assays. Phase II metabolism was assessed by HPLC measurement of formation of glucuronides and sulfates of 4-methylumbelliferone, 1-naphthol, and estradiol. The toxicity of acetaminophen, amiodarone, aspirin, clozapine, tacrine, tamoxifen, and troglitazone was monitored using a luminescent cell viability assay. Canaliculi formation was monitored by following the fluorescence of 5,6-carboxy-2',7'-dichlorofluorescein diacetate. All culture models showed similar levels of basal CYP3A4, CYP1A2 and CYP2B6 activity. However, while Prim-heps showed a vigorous response to CYP inducing agents, 2d-iPSC-heps showed no response and 3d-iPSC-heps displayed an inconclusive response. 2d-iPSC-heps showed reduced, yet appreciable, glucuronide and sulfate formation compared to Prim-heps. All culture models showed similar activity in tests of hepatotoxicity, with Prim-heps generally being more sensitive. All models formed canaliculi capable of transporting carboxy-2',7'-dichlorofluorescein. The iPSC-heps appear to be useful for toxicity and transport studies, but metabolic activity is not optimum, and metabolism studies would benefit from a more mature model.
最近已经可以从人诱导多能干细胞(iPSC-heps)中产生肝细胞,这在监管环境中可能比原代人肝细胞(Prim-heps)具有一些优势。本研究的目的是在药物代谢、肝毒性和药物转运的初步检测中,评估市售的 iPSC-heps 和 Prim-heps 之间的异同。肝细胞要么在涂有胶原蛋白的 96 孔板中培养(Prim-heps 和 2d-iPSC-heps),要么在超低附着平板中作为球体培养(3d-iPSC-heps)。3d-iPSC-heps 用于增强生理细胞-细胞接触,这对于维持成熟肝细胞的表型至关重要。细胞色素 P450(CYP)3A4、CYP1A2 和 CYP2B6 活性水平通过荧光测定法进行评估。通过 HPLC 测量 4-甲基伞形酮、1-萘酚和雌二醇的葡萄糖醛酸和硫酸盐的形成来评估 II 相代谢。使用发光细胞活力测定法监测对乙酰氨基酚、胺碘酮、阿司匹林、氯氮平、他克林、他莫昔芬和曲格列酮的毒性。通过跟踪 5,6-羧基-2',7'-二氯荧光素二乙酸酯的荧光来监测胆小管的形成。所有培养模型均显示出相似的基础 CYP3A4、CYP1A2 和 CYP2B6 活性水平。然而,虽然 Prim-heps 对 CYP 诱导剂表现出强烈的反应,但 2d-iPSC-heps 没有反应,3d-iPSC-heps 则表现出不确定的反应。与 Prim-heps 相比,2d-iPSC-heps 的葡萄糖醛酸和硫酸盐形成减少,但仍可察觉。所有培养模型在肝毒性测试中均显示出相似的活性,而 Prim-heps 通常更敏感。所有模型都形成了能够转运羧基-2',7'-二氯荧光素的胆小管。iPSC-heps 似乎可用于毒性和转运研究,但代谢活性不理想,代谢研究将受益于更成熟的模型。